Cadonilimab plus Pemetrexed and Anlotinib Clinical Trials

1 actively recruiting trial

Also known as: ICIs in combination with chemotherapy and antiangiogenic therapy

Filter by location:

Other1 trial

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.